title: [Trans-scleral diode laser cyclophotocoagulation for the treatment of refractory pediatric glaucoma].
abstract: OBJECTIVE
  To evaluate the success rate of contact diode transscleral cyclophotocoagulation (TSCPC) in pediatric refractory glaucoma.
  
  
  METHODS
  and method: Twenty-eight eyes of 28 patients (age range 5 months to 26 years) with medical and surgical refractory pediatric glaucoma due to primary congenital glaucoma (group 1, 20 eyes) or aphakic congenital glaucoma (group 2: 8 eyes), were included in this retrospective study. All eyes underwent one or more TSCPC with the diode laser (Oculight SLX, Iris Medical) with a minimal follow-up of 2 months. Success was defined as intraocular pressure (IOP) between 6 and 20 mmHg after one or more procedures, with no increase in medical hypotensive therapy, and no progression to another hypotensive procedure.
  
  
  RESULTS
  Mean baseline IOP was 29.4 +/- 7.8 mmHg (range 25 to 60 mmHg) and mean follow-up was 10.3 +/- 6.9 months (range 2 to 26 months). Success rates evaluated at 6 and 12 months (Kaplan Meier survival curves) were 54.4% and 27.7% respectively, with one-third of the eyes retreated once or more. These success rates were similar in both groups with a mean baseline IOP decrease of 38.9 +/- 15.9%. Postoperative uncontrolled hypertony occurred in the first 3 months in 6 (21.4%) eyes, leading to surgical IOP management. Other complications were decrease in visual acuity (14.3%), inflammation (25.5%) and phthisis (3.5%).
  
  
  CONCLUSIONS
  TSCPC with the diode laser is a disappointing procedure for the management of refractory pediatric glaucoma, with poor mid-term IOP control and high incidence of complications including severe uncontrolled IOP increase. For these reasons, this cyclodestructive procedure should be considered as a last resort therapy for patients with refractory pediatric glaucoma.
authors.affiliation: Centre du Glaucome, CHNO des Quinze-Vingts, 75012 Paris.
authors.forename: P
authors.initials: P
authors.lastname: Hamard
authors.forename: F
authors.initials: F
authors.lastname: May
authors.forename: S
authors.initials: S
authors.lastname: Quesnot
authors.forename: H
authors.initials: H
authors.lastname: Hamard
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005500:Follow-Up Studies; D005901:Glaucoma / Q000151:congenital / Q000601:surgery*; D006801:Humans; D007223:Infant; D017075:Laser Coagulation; D013997:Time Factors; D016896:Treatment Outcome